coronaviru
spike
protein
mediat
hostcellattach
viru
entri
viru
replic
take
place
within
host
cell
cytosol
wherea
assembl
bud
occur
endoplasm
reticulumgolgi
intermedi
compart
studi
demonstr
last
amino
acid
stretch
alphacoronaviru
spike
cytoplasm
domain
human
coronaviru
porcin
transmiss
gastroenter
viru
tgev
interact
tubulin
alpha
beta
chain
addit
partial
coloc
tgev
spike
protein
authent
host
cell
observ
furthermor
druginduc
microtubul
depolymer
led
chang
spike
protein
distribut
reduct
releas
infecti
viru
particl
less
amount
spike
protein
incorpor
virion
data
demonstr
interact
alphacoronaviru
spike
protein
tubulin
support
protein
transport
incorpor
viru
particl
von
brunn
christelschwegmann
tihohannoverd
c
contribut
equal
work
pleas
cite
articl
et
al
tubulin
interact
porcin
human
protein
genu
alphacoronaviru
support
success
assembl
releas
infecti
viral
particl
virolog
http
dx
coronavirus
cov
posit
singlestrand
rna
virus
infect
bird
mammal
especi
respiratori
gastrointestin
system
due
high
mutat
recombin
rate
coronavirus
frequent
hostshift
event
animaltoanim
animaltohuman
occur
chines
guan
et
al
lau
et
al
woo
et
al
bat
identifi
natur
reservoir
sever
acut
respiratori
syndrom
sar
outbreak
china
year
ge
et
al
li
et
al
similarli
strain
close
relat
human
cov
found
bat
ghana
corman
et
al
pfefferl
et
al
thu
specul
sever
human
anim
cov
origin
bat
liu
et
al
shi
hu
woo
et
al
cov
spike
glycoprotein
key
determin
host
rang
necessari
receptor
bind
membran
fusion
graham
baric
protein
contain
larg
ectodomain
transmembran
domain
ctermin
cytoplasm
tail
cytoplasm
domain
consist
cysteinerich
chargerich
region
mediat
incorpor
virion
result
infecti
viru
particl
bosch
et
al
godek
et
al
cov
like
transmiss
gastroenter
viru
tgev
well
hcov
contain
tyrosinebas
sort
signal
within
chargerich
region
whichin
case
tgev
proteinwa
shown
import
intracellular
retent
schwegmannwessel
et
al
free
movement
viru
particl
host
cell
cytoplasm
restrict
cytosol
highli
viscou
contain
structur
barrier
like
organel
well
cytoskelet
element
leopold
pfister
lubyphelp
verkman
therefor
diffus
viruss
particl
unlik
arriv
specif
cellular
region
compart
nearli
imposs
sodeik
consequ
mani
virus
use
cytoskeleton
network
host
cell
transport
system
reach
compart
replic
process
take
place
find
way
cell
leopold
pfister
ploubid
way
radtk
et
al
furthermor
known
cytoskeleton
play
crucial
role
viru
attach
intern
endocytosi
transcript
replic
assembl
exocytosi
well
celltocel
spread
purpos
virus
rearrang
cellular
filament
use
track
radtk
et
al
regard
tgev
actinbind
protein
filamin
put
interact
partner
tgev
protein
trincon
schwegmannwessel
case
tgevinfect
cell
actin
filament
shown
import
viral
replic
releas
zhao
et
al
addit
interact
tgev
nucleocapsid
protein
type
intermedi
filament
vimentin
shown
requir
viral
replic
well
zhang
et
al
anoth
major
compon
dynam
cytoskelet
matrix
repres
microtubul
polar
structur
built
heterodim
import
cell
shape
transport
motil
cell
divis
heald
nogal
nogal
sever
virus
known
interact
tubulin
molecular
motor
like
kinesin
dynein
biswa
da
sarma
han
et
al
hara
et
al
henri
sum
hsieh
et
al
hyde
et
al
cov
like
demyelin
strain
mous
hepat
viru
mhv
use
microtubul
neuron
spread
felin
infecti
periton
viru
fipv
transport
via
microtubul
toward
microtubul
organ
center
biswa
da
sarma
dewerchin
et
al
tgev
upregul
microtubuleassoci
detect
swine
testi
st
cell
infect
studi
present
analyz
interact
tubulin
last
amino
acid
stretch
protein
cytoplasm
tail
alphacoronavirus
like
tgev
hcov
hcov
result
show
tubulin
interact
cytoplasm
domain
spike
protein
reduc
releas
infecti
viru
particl
well
differenti
distribut
protein
observ
druginduc
tubulin
depolymer
therefor
tubulin
may
help
protein
properli
transport
local
assembl
virion
human
embryon
kidney
cell
use
coimmunoprecipit
via
gfp
trap
pull
assay
st
cell
use
immunofluoresc
analysi
plaqu
assay
cell
line
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
hypsignathu
monstrosu
kidney
cell
kuhl
et
al
pipistrellu
pipistrellu
kidney
cell
muller
et
al
provid
marcel
use
immunofluoresc
analysi
grown
dmem
supplement
fetal
calf
serum
purdu
strain
tgev
provid
l
enjuan
propag
st
cell
h
incub
supernat
harvest
centrifug
addit
fetal
calf
serum
store
fusion
protein
last
amino
acid
aa
stretch
tgev
sarscov
cytoplasm
domain
gfp
construct
use
invitrogenlif
technolog
gateway
clone
tabl
full
length
tgev
wildtyp
fuse
gfp
name
tgev
swtgfp
full
length
mutant
tgev
tyrosin
posit
exchang
alanin
fuse
gfp
name
tgev
yagfp
tubulin
ctermin
tag
ha
ypydvpdya
peptid
use
coimmunoprecipit
compart
marker
gfptag
galactosyltransferas
use
winter
et
al
full
length
tgev
cdna
transfect
coloc
studi
full
length
tgev
nucleocapsid
n
cdna
empti
gfp
plasmid
serv
neg
control
determin
interact
partner
protein
cytoplasm
domain
cell
seed
cm
dish
transfect
empti
gfp
vector
fusion
protein
one
day
later
use
lipofectamin
life
technolog
follow
manufactur
instruct
coimmunoprecipit
cell
addit
cotransfect
tubulin
candid
tag
hapeptid
use
polyethylenimin
pei
mgml
polysci
dna
mg
mix
ml
optimem
life
technolog
incub
min
follow
ml
pei
ad
incub
min
mixtur
ad
dropwis
cell
incub
overnight
cell
lyse
lysi
buffer
presenc
proteas
inhibitor
cocktail
roch
diagnost
mannheim
min
ice
follow
centrifug
min
chromotek
gfptrap
consist
agaros
bead
coat
antibodi
deriv
alpaca
gfp
use
gener
screen
method
well
specif
interact
studi
tubulin
protein
purif
done
describ
manufactur
protocol
interact
experi
nacl
concentr
wash
buffer
increas
mm
mm
avoid
unspecif
pull
tubulin
instead
ml
sd
sampl
buffer
ml
sd
sampl
buffer
use
cell
lysat
eluat
subject
sdspage
semidri
techniqu
kyhseandersen
protein
gel
transfer
nitrocellulos
membran
ge
healthcar
subsequ
block
milk
powder
tb
one
hour
incub
first
antibodi
overnight
ratantiha
antibodi
provid
e
kremmer
ratantigfp
antibodi
chromotek
next
day
membran
wash
time
tbst
min
treat
secondari
antibodi
hrpconjug
donkeyantirat
antibodi
sigmaaldrich
h
afterward
membran
wash
time
tbst
min
tb
min
blot
expos
millipor
western
chemiluminesc
hrp
substrat
fischer
scientif
visual
geldoc
document
system
regard
gener
screen
interact
partner
protein
sd
gel
fix
stain
coomassi
solut
destain
gel
visibl
band
cut
digest
analyz
mass
spectrometri
excis
gel
piec
equilibr
mm
nh
hco
subsequ
incub
h
trypsin
ngml
describ
previous
thyrock
et
al
result
proteolyt
peptid
extract
sequenti
agit
ml
mm
nh
hco
acetonitril
acn
trifluoroacet
acid
tfa
tfa
neat
acn
supernat
combin
dri
vacuo
desalt
perform
use
ziptip
per
descript
thyrock
et
al
analysi
purifi
peptid
perform
use
synapt
instrument
water
manchest
uk
equip
zspray
sourc
posit
ion
sensit
mode
sourc
paramet
sourc
temperatur
capillari
voltag
kv
sampl
cone
voltag
v
sourc
offset
voltag
v
peptid
sequenc
deduc
fragment
ion
spectra
deriv
nanoesi
ion
mobil
spectrometri
im
low
energi
cid
experi
thyrock
et
al
st
cell
use
immunofluoresc
transfect
tgev
swtgfp
tgev
yagfp
fusion
protein
tgev
sarscov
help
eurogentec
follow
manufactur
instruct
ml
per
well
altern
use
lipofectamin
life
technolog
cell
seed
plate
transfect
tgev
swtgfp
tgev
sarscov
use
lipofectamin
life
technolog
follow
manufactur
instruct
cell
express
gfp
alon
tgev
nucleocapsid
n
protein
serv
neg
control
three
hour
post
transfect
hpt
cell
mocktreat
dimethylsulfoxid
dmso
mgml
nocodazol
noc
mg
dilut
ml
dmso
h
follow
medium
chang
one
hour
later
ie
hpt
cell
fix
paraformaldehyd
pfa
pb
cell
permeabil
tritonpb
min
detect
authent
tubulin
monoclon
conjug
antibodi
produc
mice
sigmaaldrich
use
st
cell
infect
tgev
moi
h
case
cell
transfect
cdna
encod
cellular
receptor
tgev
porcin
aminopeptidas
n
papn
perform
one
day
prior
infect
one
hour
post
infect
cell
mocktreat
dmso
mgml
noc
h
follow
medium
chang
seven
hour
post
infect
hpi
cell
fix
pfa
permeabil
tgev
protein
detect
monoclon
antibodi
provid
l
enjuan
secondari
antibodi
alexa
fluor
alexa
fluor
antimous
life
technolog
use
nuclei
stain
dapi
st
cell
express
compart
marker
transfect
specif
cdna
one
day
infect
tgev
protein
encod
cdna
transfect
detect
hpt
monoclon
antibodi
provid
l
enjuan
secondari
antibodi
antimous
sigma
aldrich
use
immunofluoresc
analys
done
confoc
microscopi
use
leica
tc
st
cell
seed
plate
chiropteran
cell
transfect
cdna
encod
papn
one
day
post
seed
cell
infect
tgev
moi
one
day
transfect
incub
h
cell
wash
tree
time
medium
cultur
dmem
plu
fetal
calf
serum
supernat
ml
collect
time
point
hpi
addit
cell
either
treat
dmso
incub
mgml
noc
differ
time
point
h
infect
infect
directli
infect
regard
cell
noc
treatment
done
infect
st
cell
seed
plate
inocul
ml
collect
supernat
h
afterward
inoculum
discard
cell
treat
methylcellulos
overnight
next
day
cell
fix
pfa
treat
antibodi
viral
protein
ifa
use
nikon
eclips
ti
microscop
plaqu
form
unit
count
time
point
st
cell
seed
mm
cell
cultur
dish
one
day
later
cell
infect
tgev
moi
h
wash
cell
mocktreat
dimethyl
sulfoxid
dmso
treat
mgml
nocodazol
depolymer
microtubuli
cell
cultur
supernat
ultracentrifug
hpi
sw
rotor
beckman
coulter
h
viru
particl
pellet
solubil
ml
sd
sampl
puffer
nonreduc
condit
heat
subject
sdspage
parallel
st
cell
lyse
lysi
puffer
presenc
proteas
inhibitor
cocktail
roch
diagnost
mannheim
subject
sdspage
well
nonreduc
condit
separ
protein
transfer
nitrocellulos
membran
ge
healthcar
subsequ
block
block
reagent
roch
block
buffer
mm
maleic
acid
mm
nacl
ph
overnight
wash
membran
time
phosphat
buffer
salin
tween
pb
pb
nitrocellulos
membran
treat
antibodi
tgev
protein
mab
tgev
protein
mab
tgev
n
protein
mab
thermo
scientif
h
wash
membran
treat
antimous
peroxidaseconjug
antibodi
dako
h
chemiluminesc
peroxidas
substrat
thermo
scientif
chemi
doc
system
biorad
use
chemiluminesc
signal
detect
potenti
interact
partner
cytoplasm
domain
tgev
identifi
use
screen
method
involv
gfp
trap
pull
assay
follow
sdspage
coomassi
stain
addit
gfp
fusion
protein
three
clear
band
visibl
detect
band
identifi
mass
spectrometri
first
band
around
kda
contain
fragment
match
heat
shock
kda
protein
fragment
second
band
around
kda
refer
proalpha
chain
collagen
type
although
size
fit
expect
one
band
around
kda
match
group
tubulin
beta
chain
repres
tubulin
beta
chain
three
gene
chosen
analysi
comparison
one
gene
encod
tubulin
alpha
chain
enclos
studi
orf
chosen
gene
clone
tag
ha
valid
interact
amino
acid
stretch
tgev
protein
cytoplasm
domain
differ
tubulin
chain
protein
coimmunoprecipit
experi
perform
fig
cotransfect
hatag
tubulin
purif
done
via
gfp
trap
pull
assay
neg
control
cell
coexpress
tubulin
candid
empti
gfp
vector
use
four
tubulinha
protein
detect
lysat
similar
quantiti
expect
size
kda
consid
eluat
strong
signal
tubulinha
detect
case
coexpress
tubulin
neg
control
weak
band
unspecif
bind
visibl
similar
protein
quantiti
hatag
tubulin
cell
lysat
well
similar
quantiti
gfp
eluat
kda
strengthen
specif
interact
tgev
tubulin
coimmunoprecipit
tubulin
correspond
part
human
protein
cytoplasm
domain
similar
stretch
cytoplasm
tail
fuse
gfp
afterward
cell
cotransfect
gfp
fusion
construct
hatag
tubulin
follow
gfp
trap
pull
assay
sdspage
western
blot
fig
purifi
method
clearli
confirm
interact
partner
coprecipit
cell
cotransfect
band
eluat
weak
neg
control
tgev
swt
full
length
protein
partli
coloc
authent
cellular
interact
tgev
cytoplasm
tail
tubulin
confirm
coimmunoprecipit
confoc
microscopi
done
local
tgev
swt
full
length
protein
host
cell
fig
st
cell
express
tgev
swtgfp
fix
incub
antibodi
authent
partial
coloc
tgev
swtgfp
protein
observ
fig
white
arrow
next
step
filament
depolymer
drug
name
nocodazol
noc
use
function
analysi
stubulininteract
st
cell
transfect
either
full
length
tgev
swt
tgev
ya
mutant
fuse
gfp
last
stretch
cytoplasm
domain
tgev
sarscov
fuse
gfp
well
neg
control
cell
transfect
full
length
tgev
n
empti
gfp
plasmid
tgev
ya
mutant
abolish
retent
signal
due
mutat
tyrosin
alanin
lead
surfac
express
singl
transfect
cell
tgev
swt
protein
intracellularli
retain
schwegmannwessel
et
al
use
mutant
ya
protein
import
tyrosinebas
motif
within
cytoplasm
domain
alphacoronaviru
protein
interest
examin
addit
repres
genu
betacoronaviru
sarscov
contain
tyrosin
motif
includ
cell
mocktreat
treat
noc
hpt
analyz
cov
protein
local
earli
assembl
event
cell
fix
hpt
risco
et
al
vogel
et
al
next
authent
stain
use
specif
antibodi
fig
cell
treat
dmso
show
typic
long
filament
tubulin
structur
noc
treat
cell
characterist
filament
structur
detect
look
like
patch
camouflag
net
like
filament
anymor
differ
protein
express
pattern
could
observ
well
dmso
treat
cell
protein
accumul
near
nucleu
less
distribut
cytosol
contrast
protein
express
noc
treat
cell
scatter
throughout
cytoplasm
look
like
vesicl
phenomenon
differenti
distribut
protein
due
noc
treatment
observ
test
construct
well
differ
noc
concentr
mgml
mg
ml
although
cytoplasm
tail
fusion
protein
tgev
sarscov
show
addit
gfp
express
within
nucleu
accumul
clearli
visibl
well
alter
local
protein
noc
treatment
cell
express
gfp
alon
tgev
n
protein
show
differ
express
pattern
dmso
noc
treat
cell
fig
thu
irrespect
presenc
absenc
hydrophob
membran
anchor
sequenc
tyrosinebas
signal
protein
associ
chargerich
region
present
test
coronaviru
protein
may
import
interact
equal
distribut
singl
gfp
well
tgev
n
protein
use
control
protein
demonstr
protein
miss
chargerich
region
interact
tubulin
chiropteran
cell
also
transfect
full
length
tgev
swt
amino
acid
stretch
tgev
sarscov
cytoplasm
tail
fuse
gfp
treat
dmso
noc
fig
c
similar
result
st
cell
observ
without
noc
protein
accumul
near
nucleu
wherea
drugtreat
cell
dispers
within
cytoplasm
chiropteran
cell
line
noc
concentr
mgml
result
cytotox
effect
noc
concentr
mgml
chosen
compar
effect
tubulin
depolymer
chiropteran
st
cell
respect
st
cell
infect
tgev
fig
fixat
cell
treat
antibodi
viral
protein
immunofluoresc
analysi
hpi
express
pattern
could
observ
similar
stransfect
cell
infect
nontreat
cell
accumul
stronger
near
nucleu
compar
stransfect
cell
protein
detect
vesiclelik
structur
distribut
cytosol
incub
noc
st
cell
first
transfect
marker
ergic
golgi
compart
infect
tgev
treat
dmso
mock
noc
fig
mocktreat
cell
accumul
near
ergic
golgi
compart
hpi
assembl
cov
occur
ergic
around
hpi
partial
coloc
protein
compart
marker
could
observ
drugtreat
cell
protein
well
ergic
golgi
compart
scatter
throughout
cytoplasm
still
express
close
partial
coloc
addit
effect
distribut
tgev
protein
noc
effect
cellular
organel
effect
noc
treatment
tgev
protein
distribut
analyz
combin
ergic
golgi
tgev
swtgfp
local
h
transfect
cdna
tgev
protein
protein
scatter
throughout
cytoplasm
cell
incub
noc
fig
tgev
show
partial
coloc
ergic
golgi
compart
complet
coloc
cotransfect
tgev
swtgfp
noc
treatment
part
coloc
tgev
protein
decreas
coexpress
studi
ergic
golgi
tgev
protein
reduc
coloc
tgev
protein
depolymer
tubulin
promin
indic
mechan
direct
indirect
depend
tubulin
differ
tgev
protein
st
cell
transfect
compart
marker
ergic
golgi
compart
green
infect
tgev
tgev
protein
stain
red
hpi
b
st
cell
cotransfect
compart
marker
ergic
golgi
green
cdna
encod
tgev
protein
red
tgev
swtgfp
green
cdna
encod
tgev
protein
red
hpt
c
cell
treat
dmso
noc
cell
treat
noc
nuclei
stain
dapi
blue
immunofluoresc
analysi
perform
confoc
microscopi
use
leica
tc
st
cell
infect
tgev
treat
noc
dmso
differ
time
point
h
infect
infect
directli
infect
supernat
collect
hpi
use
viru
quantif
st
cell
via
plaqu
assay
fig
infect
st
cell
treat
drug
show
viral
titer
pfuml
hpi
contrast
cell
treat
noc
variou
time
point
titer
pfuml
hpi
measur
highli
signific
differ
viru
titer
treat
versu
untreat
cell
calcul
regard
infect
cell
sixfold
reduc
amount
releas
infecti
viru
particl
measur
noc
treatment
pfuml
compar
untreat
pfuml
cell
fig
cell
infect
tgev
show
viral
titer
pfuml
infect
noc
treat
cell
titer
pfuml
measur
fig
amount
bat
cell
express
papngfp
cell
surfac
measur
flow
cytometri
use
monoclon
papn
antibodi
provid
h
laud
percentag
papnposit
cell
mean
experi
st
cell
infect
tgev
treat
dmso
noc
cell
lysi
well
viru
particl
concentr
ultracentrifug
incorpor
virion
examin
sdspage
follow
western
blot
fig
mockinfect
cell
serv
neg
control
infect
st
cell
treat
noc
protein
detect
viru
particl
ultracentrifug
cell
treat
noc
well
mgml
weak
nearli
signal
observ
protein
incorpor
viral
particl
signal
tgev
n
protein
similar
correspond
cell
lysat
compar
amount
n
protein
detect
concentr
virion
irrespect
nocodazol
treatment
well
mgml
indic
reduc
incorpor
viru
particl
due
depolymer
tubulin
noc
treatment
infect
st
cell
virus
reli
host
cell
machineri
success
replic
belov
et
al
besk
et
al
choe
et
al
konan
et
al
moffat
et
al
oostra
et
al
sakaguchi
et
al
nevertheless
detail
knowledg
virushost
interact
would
lead
therapeut
tool
infect
control
cov
use
host
secretori
pathway
replic
cycl
vesicular
transport
secretori
pathway
mostli
mediat
microtubul
correspond
motor
protein
fokin
et
al
case
mhv
shown
earli
secretori
et
al
virolog
pathway
import
format
replic
complex
knoop
et
al
oostra
et
al
verheij
et
al
releas
infecti
progeni
incorpor
cov
protein
viru
particl
assembl
requir
inform
cellular
factor
interact
coronavir
protein
transport
assembl
would
import
understand
viru
infect
process
studi
search
interact
partner
last
stretch
tgev
hcov
cytoplasm
domain
contain
tyrosinebas
motif
four
differ
tubulin
alpha
beta
chain
detect
interact
tgev
human
regard
hcov
interact
notic
either
bind
certain
tubulin
low
affin
destroy
impair
bind
tubulin
due
gfptag
could
possibl
well
nevertheless
neg
result
demonstr
tail
coronaviru
protein
interact
tubulin
due
sticki
unstructur
peptid
conform
due
specif
bind
tubulin
mani
virus
close
associ
cytoskelet
element
shown
luftig
adenoviru
type
particl
well
reoviru
particl
interact
microtubul
babiss
et
al
luftig
weih
mile
et
al
polioviru
newli
synthes
viral
rna
simian
viru
associ
actin
filament
intermedi
filament
benzeev
et
al
lenk
penman
interact
like
necessari
initi
infect
transport
viral
compon
well
assembl
new
viral
particl
hsieh
et
al
moreov
tubulin
alreadi
found
packag
virion
epsteinbarr
viru
human
cytomegaloviru
murin
leukemia
viru
johannsen
et
al
varnum
et
al
wang
et
al
sever
virus
like
adenoviru
african
swine
fever
viru
canin
parvoviru
herp
simplex
viru
well
lyssaviru
rabi
viru
interact
either
whole
viru
capsid
singl
viral
protein
cytoplasm
dynein
examin
alonso
et
al
dougla
et
al
jacob
et
al
kelkar
et
al
raux
et
al
suikkanen
et
al
ye
et
al
virus
may
evolv
microtubulebind
motif
similar
amino
acid
sequenc
complementari
motif
dynein
success
interact
leopold
pfister
pasick
et
al
indirect
interact
protein
tubulin
via
motor
protein
like
dynein
kinesin
may
possibl
scenario
coronavirus
well
transfect
well
infect
cell
coronaviru
protein
scatter
throughout
cell
noc
treatment
shown
express
tgev
protein
differ
local
protein
noc
treatment
indic
differ
interact
tubulin
possibl
one
viral
protein
interact
indirect
way
tubulin
via
cellular
protein
redistribut
compart
marker
ergic
golgi
show
depend
two
marker
protein
tubulin
well
direct
indirect
manner
phenomenon
demonstr
possibl
exclud
viral
andor
protein
interact
cellular
protein
depend
tubulin
nevertheless
experi
visual
use
differ
mode
interact
lead
regular
incorpor
protein
viral
particl
even
noc
treatment
strong
reduct
protein
incorpor
viral
particl
redistribut
noc
treat
cell
alreadi
shown
differ
viral
protein
like
crimeancongo
hemorrhag
fever
viru
nucleocapsid
protein
simon
et
al
herp
simplex
viru
capsid
sodeik
et
al
two
test
chiropteran
cell
line
similar
result
stransfect
tgevinfect
st
cell
obtain
also
redistribut
protein
noc
treat
cell
well
less
releas
infecti
viru
particl
compar
dmso
treat
cell
notic
suggest
conserv
viral
strategi
use
host
advantag
replic
due
assumpt
mani
human
anim
cov
origin
bat
eukaryot
cell
contain
microtubul
conserv
microtubuledepend
cov
replic
strategi
like
furthermor
demonstr
noc
lead
reduc
amount
releas
infecti
viru
particl
less
viru
yield
cytoskeleton
disrupt
alreadi
shown
moloney
murin
leukemia
viru
vaccinia
viru
payn
kristensson
satak
luftig
find
step
tgev
replic
cycl
mostli
influenc
interact
tubulin
cell
drugtreat
differ
time
point
infect
significantli
lower
viru
titer
cell
cultur
supernat
noc
treat
cell
compar
untreat
cell
detect
wherea
differ
viral
titer
concern
variou
time
point
could
observ
cov
use
host
secretori
pathway
transport
ertogolgi
apparatu
well
viru
assembl
knoop
et
al
oostra
et
al
verheij
et
al
vogel
et
al
impair
transport
viral
compon
affect
assembl
protein
newli
gener
viru
particl
may
explain
decreas
viru
yield
mhv
microtubul
import
neuron
transport
replic
viral
spread
biswa
da
sarma
also
reduc
effici
viral
infect
observ
use
microtubul
disrupt
drug
biswa
da
sarma
tgev
abl
enter
cell
absenc
presenc
noc
abl
replic
egress
infect
less
effici
regard
amount
newli
form
infecti
virion
due
fact
depolymer
microtubul
inhibit
tgev
infect
complet
viru
compon
use
pathway
traffick
besid
tubulin
filament
finish
replic
cycl
actindepend
strategi
viru
movement
could
possibl
cudmor
et
al
lanier
volkman
sanlioglu
et
al
howev
lower
viru
titer
may
correl
differenti
distribut
protein
noc
treat
cell
actual
accumul
near
ergic
interact
protein
incorpor
newli
assembl
virion
nguyen
hogu
opstelten
et
al
microtubul
depolymer
protein
well
ergic
golgi
compart
scatter
throughout
cell
due
diffus
distribut
two
compart
import
success
tgev
assembl
less
interact
viral
protein
assembl
may
possibl
impair
transport
viru
particl
golgi
compart
plasma
membran
due
noc
treatment
may
also
reason
lower
viral
titer
concern
matter
less
organ
cytoplasm
dispers
golgi
stack
noc
treat
st
cell
alreadi
shown
risco
et
al
tgev
virion
seen
disrupt
golgi
stack
wherea
detect
extracellular
surfac
risco
et
al
reason
may
microtubuledepend
transport
vesicl
golgi
compart
plasma
membran
risco
et
al
find
incorpor
virion
influenc
noc
treatment
viru
particl
concentr
supernat
noctreat
infect
cell
compar
mocktreat
cell
case
amount
protein
similar
dmso
noc
treat
cell
lysat
wherea
protein
quantiti
strongli
reduc
pellet
viru
particl
infect
cell
treat
noc
fact
fit
calcul
smaller
amount
releas
infecti
viru
particl
measur
drug
treat
cell
minim
requir
assembl
viru
like
particl
express
tgev
e
structur
protein
vennema
et
al
amount
n
protein
releas
viru
particl
present
fig
reveal
nearli
variat
noc
treatment
demonstr
coronaviru
assembl
gener
disturb
depolymer
microtubul
thu
reduct
viru
titer
mainli
caus
fact
less
protein
present
assembl
site
due
impair
protein
transport
andor
incorpor
process
virion
tubulindepend
result
show
alphaand
betacoronaviru
protein
interact
chargerich
region
cytoplasm
domain
tubulin
beta
chain
interact
microtubul
facilit
tgev
replic
infect
effici
depolymer
microtubul
inhibit
complet
thu
interact
tubulin
support
effici
gener
infecti
viru
progeni
